Duchenne-izomdisztrófia: vizsgálatok itt: Lengyelország
7 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 2026. november 12.. Ask the study team whether a trial fits you.
- 3. fázisTaking peopleA Phase 3 Study to Evaluate the Safety and Efficacy of AOC 1044 (Also Referred to as Delpacibart Zotadirsen) in Participants With DMD With Gene Mutations Amenable to Exon 44 Skipping
- Where
- Gdansk
- Életkor
- 7 év to 16 év
- People
- 70 worldwide
- Run by
- Avidity Biosciences, Inc.
See details and how to joinNCT07587242 - 1/2. fázisTaking peopleA Study in Participants With Duchenne Muscular Dystrophy Amenable to Exon 44 Skipping to Evaluate the Safety and Efficacy of ENTR-601-44
- Where
- Gdansk, Warsaw
- Életkor
- 4 év to 20 év
- People
- 24 worldwide
- Run by
- Entrada Therapeutics, Inc.
See details and how to joinNCT07037862 · EU 2024-517584-23-00 - 1/2. fázisTaking peopleA Study in Participants With Duchenne Muscular Dystrophy Amenable to Exon 45 Skipping to Evaluate the Safety and Efficacy of ENTR-601-45
- Where
- Gdansk, Warsaw
- Életkor
- 4 év to 20 év
- People
- 24 worldwide
- Run by
- Entrada Therapeutics, Inc.
See details and how to joinNCT07038824 · EU 2024-517499-39-00 - 3. fázisTaking peopleEfficacy, Safety and Tolerability of Givinostat in Non-ambulant Patients With Duchenne Muscular Dystrophy
- Where
- Gdansk, Warsaw
- Életkor
- 9 év to 17 év
- People
- 138 worldwide
- Run by
- Italfarmaco
See details and how to joinNCT05933057 · EU 2023-503521-19-00 - 3. fázisTaking peopleA Phase 3, Randomized, Double-Blind, Placebo-Controlled, Global Study with an Open-Label Extension to Evaluate the Efficacy and Safety of Intravenous AOC 1044 (delpacibart zotadirsen) for the Treatment of DMD with Gene Mutations Amenable to Exon 44 Skipping
- Where
- Gdansk, Warsaw
- Életkor
- Up to 17 év
- People
- 42 worldwide
- Run by
- Avidity Biosciences Inc.
See details and how to join2025-523087-20-00 · EU 2025-523087-20-00 - 1/2. fázisNot yet taking people in LengyelországA PHASE 1/2, OPEN-LABEL, EXPLORATORY CLINICAL TRIAL TO EVALUATE THE SAFETY AND EFFICACY OF DT-DEC01 THERAPY IN PATIENTS WITH DUCHENNE MUSCULAR DYSTROPHY
- Where
- Poznan
- Életkor
- Up to 17 év
- People
- 20
- Run by
- Dystrogen Therapeutics Technology Polska Sp. z o.o.
See details and how to join2024-519004-27-00 · EU 2024-519004-27-00 - No phaseTaking peopleAssessments in Patients With Muscular Pathology and in Control Subjects : The ActiLiège Next Study
- Where
- Warsaw
- Életkor
- 1 év to 80 év
- People
- 300 worldwide
- Run by
- Centre Hospitalier Universitaire de Liege
See details and how to joinNCT05982119